Stormann; Thomas M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stormann; Thomas M..The latest application filed is for "5-fluoro-, chloro-and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5".

Company Profile

0.8.14

Stormann; Thomas M. - Salt Lake City UT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of mGluR5 antagonists for the treatment of gerd Grant 7,964,609 - Lehmann , et al. June 21, 2	2011-06-21
Compounds Grant 7,456,200 - Arora , et al. November 25, 2	2008-11-25
5-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5 App 20070255061 - Wensbo; David ; et al.	2007-11-01
G-protein fusion receptors and constructs encoding same Grant 7,262,280 - Stormann , et al. August 28, 2	2007-08-28
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20070179188 - Edwards; Louise ; et al.	2007-08-02
Human metabotropic glutamate receptor Grant 7,241,863 - Krapcho , et al. July 10, 2	2007-07-10
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists Grant 7,112,595 - Wagenen , et al. September 26, 2	2006-09-26
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20060189661 - Wagenen; Bradford Van ; et al.	2006-08-24
Use of mglur5 antagonists for the treatment of gerd App 20060128760 - Lehmann; Anders ; et al.	2006-06-15
Compounds App 20060122397 - Arora; Jalaj ; et al.	2006-06-08
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases Grant 7,053,104 - Van Wagenen , et al. May 30, 2	2006-05-30
New compounds App 20060063772 - Arora; Jalaj ; et al.	2006-03-23
Chimeric metabotropic glutamate receptors and uses thereof App 20050186658 - Gupta, Ashwani K. ; et al.	2005-08-25
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20050154027 - Wagenen, Bradford Van ; et al.	2005-07-14
Compounds App 20040152699 - Arora, Jalaj ; et al.	2004-08-05
New compounds App 20040132726 - Arora, Jalaj ; et al.	2004-07-08
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists Grant 6,660,753 - Van Wagenen , et al. December 9, 2	2003-12-09
Novel human metabotropic glutamate receptor App 20030157647 - Krapcho, Karen J. ; et al.	2003-08-21
Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases App 20030113873 - Fuller, Forrest H. ; et al.	2003-06-19
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists App 20030055085 - Wagenen, Bradford Van ; et al.	2003-03-20
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases App 20030013715 - Van Wagenen, Bradford C. ; et al.	2003-01-16
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases Grant 6,429,207 - Van Wagenen , et al. August 6, 2	2002-08-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.